Pfizer, Moderna COVID Vaccines 94 Percent Effective at Preventing Hospitalizations in Seniors, CDC Study Shows

A study from the U.S. Centers for Disease Control and Prevention (CDC) found the dual-dose Pfizer-BioNTech and Moderna COVID-19 vaccines are 94 percent effective at preventing hospitalizations among fully vaccinated adults ages 65 and older, reports CNBC . They were also 64 percent effective at preventing hospitalizations in seniors who received just one shot. The CDC evaluated 417 hospitalized adults across 14 states from January to March, and said the results were consistent with those in clinical trials. As of Tuesday, over 81 percent of U.S. adults 65 and older have received at least one shot of a COVID-19 vaccine, while more than 67 percent of U.S. adults in that age group are fully vaccinated. "The results are promising for our communities and hospitals," said CDC Director Rochelle Walensky. "As our vaccination efforts continue to expand, COVID-19 patients will not overwhelm healthcare systems — leaving hospital staff, beds, and services available for people who need them for other medical conditions." White House chief medical adviser Anthony Fauci also said Americans should reach a turning point in the pandemic "within a few weeks."